AstraZeneca Stock
AstraZeneca PLC
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United Kingdom
- CEO
- Pascal Claude Roland Soriot
- Employees
- 96,100
- Market cap
- $256.5 B
- IPO
- 12/05/1993
AstraZeneca PLC operates as a global biopharmaceutical leader based in Cambridge, United Kingdom. The company is dedicated to the entire process of bringing prescription medicines to market, spanning from initial discovery and development through manufacturing and commercialization. Its extensive portfolio addresses…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
AstraZeneca stock: price history
1D
-0.8%
1W
+3.9%
1M
+1.5%
6M
-19.2%
YTD
-5.7%
1Y
-2.2%
2Y
+5.6%
5Y
+39.5%
10Y
+171.6%
Next earnings date
Next earnings date
30/10/2026 (in 13 days)
Volatility around earnings
~30% stronger price swings than usual
Ask the agents about AstraZeneca
Analyst assessment of AstraZeneca
PRICE TARGET LOW
US$158.00
CONSENSUS
US$186.67
MEDIAN
US$185.00
PRICE TARGET HIGH
US$216.00
1
STRONG BUY
19
BUY
15
HOLD
6
SELL
0
STRONG SELL
41
TOTAL · Buy
As of: 13/02/2025
AstraZeneca stock metrics
P/E
24.72
P/B
5.09
EV/EBITDA
13.92
RETURN ON EQUITY
5.0%
NET MARGIN
16.3%
DEBT/EQUITY
0.64
DIVIDEND YIELD
1.9%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.5%
FLOAT SHARES
1,542,888,270
AVG. DAILY VOLUME (30D)
3,001,924
Insider transactions (SEC)
Sharma Mani
Sharma Mani
Sharma Mani
Sharma Mani
Sharma Mani
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -0.8%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about AstraZeneca stock
What does AstraZeneca do?
AstraZeneca PLC is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United Kingdom.
The CEO is Pascal Claude Roland Soriot, the company employs around 96,100 people.
The IPO was on 12/05/1993; the stock trades on NYSE under the ticker AZN.
What do analysts say about AstraZeneca stock?
41 analysts rate the stock, the consensus is Buy (as of 13/02/2025).
The average price target is US$186.67, ranging from US$158.00 to US$216.00, with a median of US$185.00.
This is an external assessment, not a statement by Market Jury.
When does AstraZeneca report next?
The next earnings date is 30/10/2026.
Around past earnings, price swings were roughly 30% stronger than usual.
Does AstraZeneca pay a dividend?
Yes. The last dividend was US$1.06 per share, ex-date 07/08/2026, paid on 08/09/2026.
The dividend yield is 1.9% (as of 30/06/2026).
Which stocks are comparable to AstraZeneca?
Comparable stocks include GSK, Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Roche Holding, Amgen and Gilead Sciences.
How can I get AstraZeneca stock analyzed?
Clicking "Analyze stock" lets five strategies assess AstraZeneca against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.